PharmiWeb19d
Roche receives FDA clearance with CLIA waiver for…
“Rapid molecular point-of-care testing can revolutionise the clinical ... and contain further spread by providing timely diagnosis.” said Matt Sause, CEO Roche Diagnostics. The cobas liat system ...
PharmiWeb20d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
“Rapid molecular point-of-care testing can revolutionise the clinical ... and contain further spread by providing timely diagnosis.” said Matt Sause, CEO Roche Diagnostics. The cobas liat system ...